# The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente

> **NCT01066650** · PHASE4 · COMPLETED · sponsor: **Foundation of Cardiovascular Research and Education Enschede** · enrollment: 1391 (actual)

## Conditions studied

- Coronary Artery Disease
- Angina Pectoris
- Unstable Angina Pectoris
- Coronary Stenosis
- Coronary Restenosis

## Interventions

- **DEVICE:** Endeavor Resolute (Biolinx-based Zotarolimus-eluting stent)
- **DEVICE:** Xience V (Everolimus-eluting stent)

## Key facts

- **NCT ID:** NCT01066650
- **Lead sponsor:** Foundation of Cardiovascular Research and Education Enschede
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-08
- **Final completion:** 2012-09
- **Target enrollment:** 1391 (ACTUAL)
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066650, "The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01066650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*